[Dose- and time-dependent dexamethasone effects in cold lesion-induced brain edema in the rat. Experimental research accompanying the German Ultrahigh Dexamethasone Head Injury Study (GUDHIS)]. 1990

K Deisenroth, and G Meinig, and K Schürmann
Klinische Pharmaentwicklung, E. Merck, Darmstadt.

Experiments in 157 rats were carried out to establish that dose and time of initial dexamethasone therapy after head injury to counteract brain edema are decisive for the antiedematous effect (dose/time response relationship). For this purpose various human doses (weight-related conversion): 20 mg, 100 mg, 500 mg or 2500 mg of dexamethasone with different intervals from the injury: 10 min, 20 min, 40 min or 80 min, were administered in the model of cold lesion induced brain edema. Injury-induced (without therapy), the edema and sodium values increased markedly, and the potassium values decreased. Administration of dexamethasone produced statistically significant dose- and time-dependent effects tending to achieve physiological conditions: An optimal dose of 500 mg of dexamethasone had the highest antiedematous effect, while with still higher doses the effects must be expected to recede again or even be damaging. As expected, pretraumatic dexamethasone doses had the greatest antiedematous effect: reduction by 49%. On administration up to about half an hour after the injury, clearly relevant effects (up to 28%) were still measurable. With longer time intervals between injury and initial dexamethasone administration, e.g. 1 1/2 hours, a measurable but less relevant edema reduction by about 10% can be expected. All posttraumatic effects were achieved experimentally with a maximal dexamethasone therapy period of 21 hours. If similar results are obtained in corresponding clinical studies, the practical recommendation--at least from the animal experimental viewpoint--would be to administer ultra-high cortisone doses (e.g. 500 mg of dexamethasone) as early as possible within the first 2-3 hours after head injury. A cortisone therapy period of more than 2 or 3 days does not appear appropriate. In general no side effects are to be expected with this therapy regimen.

UI MeSH Term Description Entries
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D001929 Brain Edema Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6) Brain Swelling,Cerebral Edema,Cytotoxic Brain Edema,Intracranial Edema,Vasogenic Cerebral Edema,Cerebral Edema, Cytotoxic,Cerebral Edema, Vasogenic,Cytotoxic Cerebral Edema,Vasogenic Brain Edema,Brain Edema, Cytotoxic,Brain Edema, Vasogenic,Brain Swellings,Cerebral Edemas, Vasogenic,Edema, Brain,Edema, Cerebral,Edema, Cytotoxic Brain,Edema, Cytotoxic Cerebral,Edema, Intracranial,Edema, Vasogenic Brain,Edema, Vasogenic Cerebral,Swelling, Brain
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

K Deisenroth, and G Meinig, and K Schürmann
January 1990, Advances in neurology,
K Deisenroth, and G Meinig, and K Schürmann
November 2008, Surgical neurology,
K Deisenroth, and G Meinig, and K Schürmann
January 1990, Advances in neurology,
K Deisenroth, and G Meinig, and K Schürmann
June 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
K Deisenroth, and G Meinig, and K Schürmann
January 1994, Acta neurochirurgica. Supplementum,
K Deisenroth, and G Meinig, and K Schürmann
May 2017, Neural regeneration research,
K Deisenroth, and G Meinig, and K Schürmann
June 2000, Pflugers Archiv : European journal of physiology,
K Deisenroth, and G Meinig, and K Schürmann
August 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Deisenroth, and G Meinig, and K Schürmann
December 2002, Journal of neurotrauma,
Copied contents to your clipboard!